Next Article in Journal
Bactericidal Effect of Extracts and Metabolites of Robinia pseudoacacia L. on Streptococcus mutans and Porphyromonas gingivalis Causing Dental Plaque and Periodontal Inflammatory Diseases
Next Article in Special Issue
Longevity Extension by Phytochemicals
Previous Article in Journal
Various Extraction Methods for Obtaining Stilbenes from Grape Cane of Vitis vinifera L.
Previous Article in Special Issue
Comparison of Two Species of Notopterygium by GC-MS and HPLC
Article Menu

Export Article

Open AccessReview
Molecules 2015, 20(4), 6113-6127; doi:10.3390/molecules20046113

Thapsigargin—From Thapsia L. to Mipsagargin

Department of Plant and Environmental Sciences, Faculty of Science, University of Copenhagen, Thorvaldsensvej 40, 1871 Frederiksberg, Denmark
*
Author to whom correspondence should be addressed.
Academic Editor: Marcello Iriti
Received: 25 February 2015 / Revised: 26 March 2015 / Accepted: 30 March 2015 / Published: 8 April 2015
View Full-Text   |   Download PDF [1541 KB, uploaded 8 April 2015]   |  

Abstract

The sesquiterpene lactone thapsigargin is found in the plant Thapsia garganica L., and is one of the major constituents of the roots and fruits of this Mediterranean species. In 1978, the first pharmacological effects of thapsigargin were established and the full structure was elucidated in 1985. Shortly after, the overall mechanism of the Sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) inhibition that leads to apoptosis was discovered. Thapsigargin has a potent antagonistic effect on the SERCA and is widely used to study Ca2+-signaling. The effect on SERCA has also been utilized in the treatment of solid tumors. A prodrug has been designed to target the blood vessels of cancer cells; the death of these blood vessels then leads to tumor necrosis. The first clinical trials of this drug were initiated in 2008, and the potent drug is expected to enter the market in the near future under the generic name Mipsagargin (G-202). This review will describe the discovery of the new drug, the on-going elucidation of the biosynthesis of thapsigargin in the plant and attempts to supply the global market with a novel potent anti-cancer drug. View Full-Text
Keywords: thapsigargin; mipsagargin; Thapsia garganica; pharmacology; biosynthesis; traditional use; sesquiterpene lactone thapsigargin; mipsagargin; Thapsia garganica; pharmacology; biosynthesis; traditional use; sesquiterpene lactone
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Andersen, T.B.; López, C.Q.; Manczak, T.; Martinez, K.; Simonsen, H.T. Thapsigargin—From Thapsia L. to Mipsagargin. Molecules 2015, 20, 6113-6127.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top